<VariationArchive VariationID="965677" VariationName="NM_000521.4(HEXB):c.283del (p.Glu95fs)" VariationType="Deletion" Accession="VCV000965677" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="954191" VariationID="965677">
      <GeneList>
        <Gene Symbol="HEXB" FullName="hexosaminidase subunit beta" GeneID="3074" HGNC_ID="HGNC:4879" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="74640023" stop="74721288" display_start="74640023" display_stop="74721288" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="73980968" stop="74017112" display_start="73980968" display_stop="74017112" Strand="+" />
          </Location>
          <OMIM>606873</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000521.4(HEXB):c.283del (p.Glu95fs)</Name>
      <CanonicalSPDI>NC_000005.10:74685541:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="74685542" stop="74685542" display_start="74685542" display_stop="74685542" variantLength="1" positionVCF="74685541" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="73981367" stop="73981367" display_start="73981367" display_stop="73981367" variantLength="1" positionVCF="73981366" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>E95fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.74685543del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.74685543del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.73981368del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.73981368del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009770.2" sequenceAccession="NG_009770" sequenceVersion="2" change="g.50521del">
            <Expression>NG_009770.2:g.50521del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000521.4" sequenceAccession="NM_000521" sequenceVersion="4" change="c.283del" MANESelect="true">
            <Expression>NM_000521.4:c.283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000512.2" sequenceAccession="NP_000512" sequenceVersion="2" change="p.Glu95fs">
            <Expression>NP_000512.2:p.Glu95fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001292004.2" sequenceAccession="NM_001292004" sequenceVersion="2" change="c.-376-3785del">
            <Expression>NM_001292004.2:c.-376-3785del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1748845774" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000521.4(HEXB):c.283del (p.Glu95fs) AND Sandhoff disease" Accession="RCV001240185" Version="5">
        <ClassifiedConditionList TraitSetID="1058">
          <ClassifiedCondition DB="MedGen" ID="C0036161">Sandhoff disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-06-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18758829</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7550345</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1058" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4366" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Beta-hexosaminidase-beta-subunit deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GM2 gangliosidosis, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Total hexosaminidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hexosaminidase A and B deficiency Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sandhoff-Jatzkewitz-Pilz disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GM2-GANGLIOSIDOSIS, TYPE II</ElementValue>
                <XRef Type="MIM" ID="268800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEXOSAMINIDASES A AND B DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="268800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sandhoff disease</ElementValue>
                <XRef ID="Sandhoff+disease/6408" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010006" DB="MONDO" />
                <XRef ID="23849003" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2521" />
                <XRef ID="2521" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Sandhoff disease comprises a phenotypic continuum encompassing acute infantile, subacute juvenile, and late-onset disease. Although classification into these phenotypes is somewhat arbitrary, it is helpful in understanding the variation observed in the timing of disease onset, presenting manifestations, rate of progression, and life span. Acute infantile Sandhoff disease (onset age &lt;6 months). Infants are generally normal at birth followed by progressive weakness and slowing of developmental progress, then developmental regression and severe neurologic impairment. Seizures are common. Death usually occurs between ages two and three years. Subacute juvenile Sandhoff disease (onset age 2-5 years). After attaining normal developmental milestones, developmental progress slows, followed by developmental regression and neurologic impairment (abnormal gait, dysarthria, and cognitive decline). Death (usually from aspiration) typically occurs in the early to late teens. Late-onset Sandhoff disease (onset older teen years or young adulthood). Nearly normal psychomotor development is followed by a range of neurologic findings (e.g., weakness, spasticity, dysarthria, and deficits in cerebellar function) and psychiatric findings (e.g., deficits in executive function and memory). Life expectancy is not necessarily decreased.</Attribute>
                <XRef ID="NBK579484" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35420740</ID>
                <ID Source="BookShelf">NBK579484</ID>
              </Citation>
              <XRef ID="796" DB="Orphanet" />
              <XRef ID="C0036161" DB="MedGen" />
              <XRef ID="MONDO:0010006" DB="MONDO" />
              <XRef Type="MIM" ID="268800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2748181" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="8194503|MedGen:C0036161" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001413110" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7550345</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18758829</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu95Argfs*59) in the HEXB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HEXB are known to be pathogenic (PMID: 7550345, 18758829). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with HEXB-related conditions. ClinVar contains an entry for this variant (Variation ID: 965677). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.73981367del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0036161" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2748181" TraitType="Disease" MappingType="XRef" MappingValue="C0036161" MappingRef="MedGen">
        <MedGen CUI="C0036161" Name="Sandhoff disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

